Jung Eun-kyung "Oral Treatment, Expansion to High-Risk Groups Under 40 Under Review"

National Assembly Budget and Accounts Special Committee Subcommittee

Jung Eun-kyung, Commissioner of the Korea Disease Control and Prevention Agency, is listening to Prime Minister Kim Boo-kyum's opening remarks at the Central Disaster and Safety Countermeasures Headquarters meeting on COVID-19 held on the 15th at the Government Seoul Office in Jongno-gu, Seoul. Photo by Kim Hyun-min kimhyun81@

[Asia Economy Reporter Jang Sehee] Jeong Eun-kyung, Commissioner of the Korea Disease Control and Prevention Agency, stated regarding the administration of oral COVID-19 treatments, "The eligibility is expanding to include people under their 40s who have high-risk factors," and that this is under review.

Commissioner Jeong appeared before the National Assembly Budget and Accounts Committee subcommittee on the 9th and said, "There are demands among experts to expand the age range for administration."

Regarding the selection of recipients for the treatment, Commissioner Jeong said, "While severe cases and underlying conditions are factors, age appears to be the most significant variable," adding, "We will select appropriate recipients in consultation with medical institutions."

On the outlook for the spread of COVID-19 following the Omicron variant, she said, "It is difficult to make definitive statements due to the risks and uncertainties of new variant emergence."

This content was produced with the assistance of AI translation services.